TZAR
LABS
UK

Tzar Labs UK
has opened in London

Tzar Labs have opened their laboratory in London, joining the Singapore and Indian facilities. The HrC Genomics cancer screening test and the BCube Tests for cancer, diabetes, cardiovascular disease, and neurodegenerative disease are now available.

Please contact Steve Smith with any inquiries on 020 8050 2578 or contact.uk@tzarlabs.com
The HrC Genomics Test

The HrC Genomics test is a breakthrough blood test which evaluates the expression levels of rare stem cell markers which may be indicative of cancer. Capable of detecting all cancer types in a single blood test, it has a sensitivity/accuracy of 90% plus, including at Stage One. The HrC Genomics test provides an indication of the likelihood of the presence or absence of cancer. It has won the 2025 Edison Gold Award for Innovation.

The BCube Tests

The B-Cube Tests are geno-molecular analyses that use transcriptome based NGS data focused on disease- linked markers and genetic pathways. A comprehensive report (approx. 20–30 pages) is provided, with an optional Orthomolecular and Pharmacotranscriptomic Report available for clinicians. Any test record is completely anonymous.

The BCube Tests currently available are:
• BCube Onco

For those who have a family history of cancer, have been diagnosed with cancer, are survivors of cancer, according more detailed information than the HrC screening test. The data can help clinicians understand the functioning of the cells that cause cancer. Results can help monitor treatment efficacy and also to provide cancer patients to early treatment direction.

• BCube Diabetes

For diabetic and pre-diabetic patients to understand their condition.

• BCube Cardiac

For patients who have known cardiovascular issues, and also for those without a current diagnosis who have a family history of cardiovascular disease, including Alzheimer's, Parkinson's, and Huntington's Disease.

• BCube Neuro

This test evaluates the risk/status of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's Disease.

Edison Gold Award 2025